Biotech · Private company · Princeton, NJ, US
Regenosine Inc
Track this companyFree. Adds Regenosine Inc to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Treatment and prevention of osteoarthritis with an intra-articular disease-modifying regenerative therapyFiscal year 2025 · $399.4KNIH RePORTER 5SB1AR084381-02 · fetched Nov 12, 2026
- Treatment and prevention of osteoarthritis with an intra-articular disease-modifying regenerative therapyFiscal year 2024 · $398.4KNIH RePORTER 1SB1AR084381-01 · fetched Nov 12, 2026